2021 MACH-Track Cohort
We are delighted to announce our inaugural MACH-Track trainees who commenced in 2021. The trainees are completing their first year in the program continuing their clinical specialty training, and at the same time, and have completed a number off mini-projects in preparation for their PhD years starting in 2022. We will be sharing the latest updates on their work in our newsletters, on Twitter and on our website.
Meet our 2021 MACH-Track trainees
Dr Emma Boehm
Dr Emma Boehm completed a Bachelor of Science in 2010 and graduated with distinction as part of the first cohort of the Melbourne MD in 2014. She has worked in wet labs including the MCRI (UROP Scholarship), and the WEHI throughout her MD.
Her clinical training and first year of endocrinology advanced training was at the Royal Melbourne Hospital, and she is currently in her second year of endocrinology training at Western Health. She will start dual training in Nuclear Medicine in 2021 and aims to use the knowledge obtained in these two specialties to investigate neuroendocrine tumour biology and treatment.
Dr Thomas Lew
Dr Thomas Lew is a Haematology trainee at the Victorian Comprehensive Cancer Centre, with a passionate drive to improve care for patients with haematological malignancies.
At Monash University, while obtaining a first-class honours at the Australian Centre for Blood Diseases, he received the Scholarship for Excellence and the Australian Medical Association Student Prize .
His research into novel agents for haematological malignancies has been published in multiple journals, including Blood and Cancer Discovery. Dr Lew has received numerous young investigator awards for presentations at international haematology conventions.
Dr Ryan McMahon
Dr Ryan McMahon is a current Radiation Oncology trainee based at the Peter MacCallum Cancer Centre. Dr McMahon completed his Medical Degree at the University of Melbourne in 2014 and then his Internship and Resident training at St. Vincent’s Hospital.
He has an interest in investigating the role of combined immunotherapy and radiotherapy in the management of solid organ malignancies.
Dr Maitri Munsif
Dr Maitri Munsif is in her second year of Respiratory & Sleep Advanced training at Austin Health. She completed her Bachelor of Medicine & Surgery at the University of Tasmania and Respiratory advanced training at Alfred Health.
She holds a Masters of Public Health (USYD), is involved in several national college and specialty training committees and is a member of the writing group for acute oxygen guidelines. She teaches medical students regularly through the Austin Clinical School with the University of Melbourne.
Maitri aspires to be an outstanding clinical researcher and academic leader. Through MACH-Track, she hopes to pursue a PhD in advanced lung disease, specifically Chronic Obstructive Pulmonary Disease (COPD), evaluating treatable traits followed by targeted treatment interventions. She hopes that to improve the treatment paradigm for these patients to ultimately reduce hospital admissions and improve their quality of life.
Dr Brent Venning
Dr Brent Venning is a General Practice Registrar with a background in public health and research interests in the early recognition and diagnosis of cancer in primary care. He graduated from medicine at the University of Wollongong in 2016 with first prizes in medicine, pharmacology, paediatrics and surgery.
He has developed further skills in epidemiology and health services research through the completion of a Master of Public Health with Excellence at the University of New South Wales.
Dr Venning was awarded a competitive academic post through the Royal Australian College of General Practitioners, where he will be undertaking a discrete choice experiment relating to polygenic cancer risk scores in primary care, with Professor Jon Emery and the Cancer in Primary Care Research Group at the University of Melbourne.